EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Impel Pharmaceuticals Inc (IMPL) stock?

You can purchase shares of Impel Pharmaceuticals Inc (OTC: IMPL) through any online brokerage.

View our list of the best stock brokerages.

Who are Impel Pharmaceuticals Inc's (IMPL) competitors?

There are no as such competitors for Impel Pharmaceuticals Inc.

What is the target price for Impel Pharmaceuticals Inc (IMPL) stock?

The latest price target for Impel Pharmaceuticals Inc (OTC: IMPL) was reported by Wedbush on Tuesday, November 15, 2022. The analyst firm set a price target for 5.00 expecting IMPL to rise to within 12 months (a possible 9900.00% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Impel Pharmaceuticals Inc (IMPL)?

The stock price for Impel Pharmaceuticals Inc (OTC: IMPL) is $0.05 last updated December 20, 2023 at 9:22 AM EST.

Does Impel Pharmaceuticals Inc (IMPL) pay a dividend?

There are no upcoming dividends for Impel Pharmaceuticals Inc.

When is Impel Pharmaceuticals Inc (OTC:IMPL) reporting earnings?

Impel Pharmaceuticals Inc’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Impel Pharmaceuticals Inc (IMPL) going to split?

There is no upcoming split for Impel Pharmaceuticals Inc.

What sector and industry does Impel Pharmaceuticals Inc (IMPL) operate in?

Impel Pharmaceuticals Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.